Autoregulation of MARCH1 expression by dimerization and autoubiquitination

Journal of Immunology

Volumn 188, Issue 10, 2012, Pages 4959-4970

  Bourgeois Daigneault, Marie Claude ^a   Thibodeau, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MEMBRANE ASSOCIATED RING CH 1 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOREGULATION; CARBOXY TERMINAL SEQUENCE; CELL STRAIN HEK293; CONTROLLED STUDY; DIMERIZATION; ENERGY TRANSFER; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MUTAGENESIS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; UBIQUITINATION; WESTERN BLOTTING;

HEK293 CELLS; HELA CELLS; HUMANS; PROTEIN BIOSYNTHESIS; PROTEIN MULTIMERIZATION; TRANSFECTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84861155773     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102708     Document Type: Article

References (59)

1. d'Azzo, A., A. Bongiovanni, and T. Nastasi. 2005. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 6: 429-441. (Pubitemid 40740384)
2. Deshaies, R. J., and C. A. Joazeiro. 2009. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78: 399-434.
3. Cadwell, K., and L. Coscoy. 2005. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309: 127-130. (Pubitemid 40934990)
4. Wang, X., R. A. Herr, W. J. Chua, L. Lybarger, E. J. Wiertz, and T. H. Hansen. 2007. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 177: 613-624. (Pubitemid 46799833)
5. Ishido, S., E. Goto, Y. Matsuki, and M. Ohmura-Hoshino. 2009. E3 ubiquitin ligases for MHC molecules. Curr. Opin. Immunol. 21: 78-83.
6. Ikeda, F., and I. Dikic. 2008. Atypical ubiquitin chains: new molecular signals: "Protein Modifications: Beyond the Usual Suspects" review series. EMBO Rep. 9: 536-542. (Pubitemid 351772916)
7. Hicke, L., H. L. Schubert, and C. P. Hill. 2005. Ubiquitin-binding domains. Nat. Rev. Mol. Cell Biol. 6: 610-621. (Pubitemid 41081265)
8. Ye, Y., and M. Rape. 2009. Building ubiquitin chains: E2 enzymes at work. Nat. Rev. Mol. Cell Biol. 10: 755-764.
9. Boname, J. M., M. Thomas, H. R. Stagg, P. Xu, J. Peng, and P. J. Lehner. 2010. Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains. Traffic 11: 210-220.
10. Ohmura-Hoshino, M., E. Goto, Y. Matsuki, M. Aoki, M. Mito, M. Uematsu, H. Hotta, and S. Ishido. 2006. A novel family of membrane-bound E3 ubiquitin ligases. J. Biochem. 140: 147-154. (Pubitemid 44618899)
11. Bartee, E., M. Mansouri, B. T. Hovey Nerenberg, K. Gouveia, and K. Früh. 2004. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78: 1109-1120. (Pubitemid 38095821)
12. Matsuki, Y., M. Ohmura-Hoshino, E. Goto, M. Aoki, M. Mito-Yoshida, M. Uematsu, T. Hasegawa, H. Koseki, O. Ohara, M. Nakayama, et al. 2007. Novel regulation of MHC class II function in B cells. EMBO J. 26: 846-854.
13. Corcoran, K., M. Jabbour, C. Bhagwandin, M. J. Deymier, D. L. Theisen, and L. Lybarger. 2011. Ubiquitin-mediated regulation of CD86 protein expression by the ubiquitin ligase membrane-associated RING-CH-1 (MARCH1). J. Biol. Chem. 286: 37168-37180.
14. De Gassart, A., V. Camosseto, J. Thibodeau, M. Ceppi, N. Catalan, P. Pierre, and E. Gatti. 2008. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc. Natl. Acad. Sci. USA 105: 3491-3496. (Pubitemid 351723580)
15. Baravalle, G., H. Park, M. McSweeney, M. Ohmura-Hoshino, Y. Matsuki, S. Ishido, and J. S. Shin. 2011. Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells. J. Immunol. 187: 2966-2973.
16. Berger, A. C., and P. A. Roche. 2009. MHC class II transport at a glance. J. Cell Sci. 122: 1-4.
17. Young, L. J., N. S. Wilson, P. Schnorrer, A. Proietto, T. ten Broeke, Y. Matsuki, A. M. Mount, G. T. Belz, M. O'Keeffe, M. Ohmura-Hoshino, et al. 2008. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 9: 1244-1252.
18. Thibodeau, J., M. C. Bourgeois-Daigneault, G. Huppé, J. Tremblay, A. Aumont, M. Houde, E. Bartee, A. Brunet, M. E. Gauvreau, A. de Gassart, et al. 2008. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur. J. Immunol. 38: 1225-1230.
19. Jabbour, M., E. M. Campbell, H. Fares, and L. Lybarger. 2009. Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression. J. Immunol. 183: 6500-6512.
20. de Bie, P., and A. Ciechanover. 2011. Ubiquitination of E3 ligases: self-regulation of the ubiquitin system via proteolytic and non-proteolytic mechanisms. Cell Death Differ. 18: 1393-1402.
21. Scialpi, F., M. Malatesta, A. Peschiaroli, M. Rossi, G. Melino, and F. Bernassola. 2008. Itch self-polyubiquitylation occurs through lysine-63 linkages. Biochem. Pharmacol. 76: 1515-1521.
22. Fang, S., J. P. Jensen, R. L. Ludwig, K. H. Vousden, and A. M. Weissman. 2000. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275: 8945-8951. (Pubitemid 30180252)
23. Kawai, H., V. Lopez-Pajares, M. M. Kim, D. Wiederschain, and Z. M. Yuan. 2007. RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity. Cancer Res. 67: 6026-6030. (Pubitemid 47037481)
24. Linke, K., P. D. Mace, C. A. Smith, D. L. Vaux, J. Silke, and C. L. Day. 2008. Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans. Cell Death Differ. 15: 841-848. (Pubitemid 351524426)
25. Hoer, S., L. Smith, and P. J. Lehner. 2007. MARCH-IX mediates ubiquitination and downregulation of ICAM-1. FEBS Lett. 581: 45-51. (Pubitemid 44960277)
26. Haque, M., J. Chen, K. Ueda, Y. Mori, K. Nakano, Y. Hirata, S. Kanamori, Y.Uchiyama, R. Inagi, T. Okuno, and K. Yamanishi. 2000. Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J. Virol. 74: 2867-2875. (Pubitemid 30117598)
27. Sanchez, D. J., L. Coscoy, and D. Ganem. 2002. Functional organization of MIR2, a novel viral regulator of selective endocytosis. J. Biol. Chem. 277: 6124-6130. (Pubitemid 34968400)
28. Lehner, P. J., S. Hoer, R. Dodd, and L. M. Duncan. 2005. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol. Rev. 207: 112-125. (Pubitemid 41415012)
29. Lampson, L. A., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125: 293-299. (Pubitemid 10040437)
30. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 14: 9-20. (Pubitemid 8340429)
31. Newton, K., M. L. Matsumoto, I. E. Wertz, D. S. Kirkpatrick, J. R. Lill, J. Tan, D. Dugger, N. Gordon, S. S. Sidhu, F. A. Fellouse, et al. 2008. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 134: 668-678.
32. Baril, M., M. E. Racine, F. Penin, and D. Lamarre. 2009. MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J. Virol. 83: 1299-1311.
33. Herr, R. A., J. Harris, S. Fang, X. Wang, and T. H. Hansen. 2009. Role of the RING-CH domain of viral ligase mK3 in ubiquitination of non-lysine and lysine MHC I residues. Traffic 10: 1301-1317.
34. Perroy, J., S. Pontier, P. G. Charest, M. Aubry, and M. Bouvier. 2004. Real-time monitoring of ubiquitination in living cells by BRET. Nat. Methods 1: 203-208.
35. Weissman, A. M., N. Shabek, and A. Ciechanover. 2011. The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation. Nat. Rev. Mol. Cell Biol. 12: 605-620.
36. Bergink, S., F. A. Salomons, D. Hoogstraten, T. A. Groothuis, H. de Waard, J. Wu, L. Yuan, E. Citterio, A. B. Houtsmuller, J. Neefjes, et al. 2006. DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2A. Genes Dev. 20: 1343-1352. (Pubitemid 43727594)
37. Duncan, L. M., S. Piper, R. B. Dodd, M. K. Saville, C. M. Sanderson, J. P. Luzio, and P. J. Lehner. 2006. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 25: 1635-1645.
38. Plechanovová, A., E. G. Jaffray, S. A. McMahon, K. A. Johnson, I. Navrátilová, J. H. Naismith, and R. T. Hay. 2011. Mechanism of ubiquitylation by dimeric RING ligase RNF4. Nat. Struct. Mol. Biol. 18: 1052-1059.
39. Oh, Y. M., S. J. Yoo, and J. H. Seol. 2007. Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity. Biochem. Biophys. Res. Commun. 357: 615-619. (Pubitemid 46653823)
40. Hewitt, E. W., L. Duncan, D. Mufti, J. Baker, P. G. Stevenson, and P. J. Lehner. 2002. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J. 21: 2418-2429. (Pubitemid 34546714)
41. Meng, L., R. Mohan, B. H. Kwok, M. Elofsson, N. Sin, and C. M. Crews. 1999. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. Proc. Natl. Acad. Sci. USA 96: 10403-10408. (Pubitemid 29422570)
42. Gelman, M. S., E. S. Kannegaard, and R. R. Kopito. 2002. A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 277: 11709-11714. (Pubitemid 34952724)
43. Fang, S., K. L. Lorick, J. P. Jensen, and A. M. Weissman. 2003. RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. Semin. Cancer Biol. 13: 5-14. (Pubitemid 36269176)
44. Grommé, M., and J. Neefjes. 2002. Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol. Immunol. 39: 181-202. (Pubitemid 35013511)
45. Xu, Y., D. W. Piston, and C. H. Johnson. 1999. A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc. Natl. Acad. Sci. USA 96: 151-156. (Pubitemid 29036068)
46. Pfleger, K. D., R. M. Seeber, and K. A. Eidne. 2006. Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat. Protoc. 1: 337-345.
47. Liew, C. W., H. Sun, T. Hunter, and C. L. Day. 2010. RING domain dimerization is essential for RNF4 function. Biochem. J. 431: 23-29.
48. Brzovic, P. S., P. Rajagopal, D. W. Hoyt, M. C. King, and R. E. Klevit. 2001. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8: 833-837. (Pubitemid 32923599)
49. Bartee, E., A. McCormack, and K. Früh. 2006. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2: e107.
50. Walseng, E., K. Furuta, B. Bosch, K. A. Weih, Y. Matsuki, O. Bakke, S. Ishido, and P. A. Roche. 2010. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proc. Natl. Acad. Sci. USA 107: 20465-20470.
51. Tze, L. E., K. Horikawa, H. Domaschenz, D. R. Howard, C. M. Roots, R. J. Rigby, D. A. Way, M. Ohmura-Hoshino, S. Ishido, C. E. Andoniou, et al. 2011. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10- driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208: 149-165.
52. Bania, J., E. Gatti, H. Lelouard, A. David, F. Cappello, E. Weber, V. Camosseto, and P. Pierre. 2003. Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs. Proc. Natl. Acad. Sci. USA 100: 6664-6669. (Pubitemid 36666638)
53. Hicke, L., and R. Dunn. 2003. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 19: 141-172. (Pubitemid 37487346)
54. Vembar, S. S., and J. L. Brodsky. 2008. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell Biol. 9: 944-957.
55. Ward, C. L., S. Omura, and R. R. Kopito. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83: 121-127.
56. Bonifacino, J. S., and L. M. Traub. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72: 395-447. (Pubitemid 36930451)
57. Alwan, H. A., E. J. van Zoelen, and J. E. van Leeuwen. 2003. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination. J. Biol. Chem. 278: 35781-35790. (Pubitemid 37102355)
58. Peschard, P., G. Kozlov, T. Lin, I. A. Mirza, A. M. Berghuis, S. Lipkowitz, M. Park, and K. Gehring. 2007. Structural basis for ubiquitin-mediated dimerization and activation of the ubiquitin protein ligase Cbl-b. Mol. Cell 27: 474-485. (Pubitemid 47126940)
59. Goto, E., S. Ishido, Y. Sato, S. Ohgimoto, K. Ohgimoto, M. Nagano-Fujii, and H. Hotta. 2003. c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity. J. Biol. Chem. 278: 14657-14668. (Pubitemid 36799788)